Search
Thursday 24 September 2015
  • :
  • :
Latest Update

News Review - Freeport-McMoRan Inc. (NYSE:FCX), Great Basin Scientific, Inc. (NASDAQ:GBSN), Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

On Friday, Shares of Freeport-McMoRan Inc. (NYSE:FCX), lost -4.15% to $9.71.

Freeport-McMoRan has hired JPMorgan Chase & Co to assist it explore options, a person familiar with the matter said on Friday, after activist investor Carl Icahn called the company undervalued and asked for corporate changes, according to Reuters.

The person asked not to be identified because the matter is confidential.

Bloomberg, which first stated the news on Friday, said the miner was considering options such as asset sales and cost cuts. However, the negotiations were at an early stage, Bloomberg said, citing people familiar with the matter.

Freeport-McMoRan declined to comment and JPMorgan Chase was not right away available for comment outside of regular U.S. business hours.

Freeport-McMoRan Inc., a natural resource company, engages in the acquisition of mineral assets, and oil and natural gas resources. It primarily explores for copper, gold, molybdenum, cobalt, silver, and other metals, in addition to oil and gas.

Shares of Great Basin Scientific, Inc. (NASDAQ:GBSN), declined -1.07% to $0.17, during its last trading session, hitting its lowest level.

Great Basin Scientific declared that President and CEO Ryan Ashton and CFO Jeffrey Rona will speak at two forthcoming investment conferences in New York City, counting:

  • Rodman & Renshaw 17th Annual Global Investment Conference on September 9 at 9:10am E.T.
  • SeeThru Equity Fall Microcap Investor Conference on September 10 at 10:00 AM E.T.

Great Basin Scientific, Inc., a molecular diagnostic testing company, doing business as Great Basin Corporation, develops and commercializes molecular diagnostic systems that are designed to test hospital-attained infections.

Finally, Walgreens Boots Alliance, Inc. (NASDAQ:WBA), ended its last trade with -0.94% loss, and closed at $87.43.

Walgreens and Providence Health & Services declared a planned clinical partnership aimed at coordinating patient care and improving patient access, which plans to bring up to 25 new retail clinics to Oregon and Washington. The clinics will be owned and operated by Providence and its associates, and become the first to open at Walgreens stores under a new collaborative services model.

Providence Express Care at Walgreens, or Swedish Express Care at Walgreens in the Seattle area, will provide an integrated health care option for patients with a known, trusted provider, while assisting to evolve the retail clinic model from urgent episodic care to more coordinated care. In the near term, Walgreens and Providence will open three clinics in both the Portland and Seattle areas in early 2016, with plans for further expansion within the next two years.

The Providence and Swedish electronic health record platform will connect directly to the clinics to create a seamless experience no matter where patients choose to access care. Information, and more importantly, care, is coordinated between visits, leading to overall better long-term health administration for the consumer.

Walgreens Boots Alliance, Inc., together with its auxiliaries, operates a network of drugstores in the United States. It provides consumer goods and services, pharmacy, and health and wellness services through drugstores, in addition to through mail, and by telephone and online.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.

 




Leave a Reply

Your email address will not be published. Required fields are marked *